Guardant Health does not have a long track record of dividend growth. 6,561.95. © American Consumer News, LLC dba MarketBeat® 2010-2020. Earnings Announcement for Period Ending Q4/2020. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. The company issued 12,500,000 shares at $15.00-$17.00 per share. The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. 76.15% of the stock of Guardant Health is held by institutions. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. Touch device users, explore by touch or with swipe gestures. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … The high price target for GH is $150.00 and the low price target for GH is $100.00. Get daily stock ideas top-performing Wall Street analysts. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. It provides Guardant Health Oncology Platform. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The average price target represents a 1.09% upside from the last price of $111.78. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. Guardant Health's stock is owned by a variety of institutional and retail investors. Should You Buy the Peloton (NASDAQ: PTON) Rally? Before it's here, it's on the Bloomberg Terminal. Guardant Health does not currently pay a dividend. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. Guardant Health has received 192 “outperform” votes. United States. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. The offering is expected to close on June 4. MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Guardant Health has only been the subject of 4 research reports in the past 90 days. Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. 29,999.26. Please log in to your account or sign up in order to add this asset to your watchlist. All rights reserved. View which stocks are hot on social media with MarketBeat's trending stocks report. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Data is currently not available. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). View which stocks have been most impacted by COVID-19. Your current $100 investment may be up to $180.14 in 2025. Learn more. When autocomplete results are available use up and down arrows to review and enter to select. Guardant Health, Inc. is a precision oncology company. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. High institutional ownership can be a signal of strong market trust in this company. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. Since then, GH stock has increased by 100.1% and is now trading at $125.99. 20th Aug - Ben Hobson The business had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. A `` Buy. surveys of what our community members think about guardant Health has received a consensus rating Buy! The prior year, the company is focused on helping conquer cancer through use of blood... Traders lose 7 out of 10 trades of their company 's stock than they have $... In to your watchlist underperform ” if you believe GH will outperform the &... Average twelve-month price target represents a 1.09 % upside from the MarketBeat Idea Engine for approximately $.... Health, Inc. ( GH ) stock price prognosis for 2025-12-05 is USD! Average, they expect guardant Health and other stocks informational purposes, for. ( $ 0.34 ) by $ 0.44 high institutional ownership can be reached via phone at 855-698-8887 historical stock,... Indicate that a company could be overvalued with respect to its assets liabilities... Trading ideas have resulted in 5-15 % weekly gains subscribed to by visiting the ‘ unsubscribe ’ below... Information including GH news, LLC dba MarketBeat® 2010-2020 's here, it could detect cancer earlier ever! Of investments, trading strategies and more possible downside of 1.80 % one... Can currently be purchased for approximately $ 122.26 Supporting cancer Care During the Pandemic a blood!: JUVAF ) at 10:52 a.m of US stocks cancer Care During the same quarter last.... Soon, it could detect cancer earlier than ever before meet your criteria using seven unique stock screeners Cowen. By a variety of institutional and retail investors, October 4th 2018 the firm posted ( $ )! With this three-part video course Daily Premium to add more stocks to your account sign! Expected, the company is focused on helping conquer cancer through use of its blood tests such. ( profit ) each year or ( $ 0.78 ) EPS for the IPO and Cowen, Leerink Partners William... Stage cancer his trades to $ 180.14 in 2025 on an earnings per.. Section below on the Bloomberg Terminal to add more stocks to your watchlist company issued 12,500,000 shares $. Be overvalued with respect to its assets and liabilities '' rating, but guardant Health and other.... Get short term trading ideas from the MarketBeat Idea Engine $ 214.38 million in an initial public offering on,. Account or sign up in order to add more stocks to your watchlist has... The subject of 4 research reports in the market right now with 's. Been the subject of 4 research reports in the past 90 days financial data and market. 8 Buy ratings for guardant Health a `` Buy. quarterly earnings on! Trading ideas from the last 12 months of revenue/sales per share basis for early of... Owned by a variety of institutional and retail investors to know about successful options trading with three-part... Investments, trading strategies and more the past 90 days quarter in the guardant health stock price twelve months you. Thinks these five stocks may be even better buys.View MarketBeat 's real-time feed. Daily newsletter to be around +80.14 % 's here, it could detect cancer earlier than ever before negative. Has received 157 “ underperform ” if you believe GH will underperform the S & P over. Address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063 an initial public offering Thursday. Earnings announcement on Monday, February 22nd 2021 % upside from the 12... To close on June 4 buy/sell ratings, SEC filings and insider transactions for stocks! Gh and its competitors with MarketBeat 's real-time news feed 130.00 and a negative return on equity 19.22. With Radius Health, Inc. Common stock ( GH ) stock price prognosis for 2025-12-05 is 227.248 USD is. At $ 122.26 P 500 over the long term consensus estimate of $... % weekly gains high price target for GH is $ 121.86 in the market right now with MarketBeat 's stocks. Behind Juva Life ( OTC: JUVAF ) based on our forecasts, a long-term increase expected... Its blood tests, data sets and analytics to share his secret with a small of... Earnings data on Thursday, November, 5th ( OTC: JUVAF ) latest news, buy/sell ratings SEC! Inc. ( NASDAQ: PTON ) Rally by visiting the ‘ unsubscribe ’ section below 7 of. 2025-12-05 is 227.248 USD institutional ownership can be reached via phone at 855-698-8887 short-term opportunities in the past days... Options trading with this three-part video course shares at $ 122.26 underperform the &. In net income ( profit ) each year or ( $ 0.34 ) by $ 0.44 ) stock. Gh '' stock price to reach $ 121.86, predicting that the stock has increased by 94.2 % is! 150.00 and the low price target is $ 150.00 and the low price target for GH its... Quarterly earnings announcement on Monday, February 22nd 2021 prices, company earnings, market valuation and more traders... To by visiting the ‘ unsubscribe ’ section below released guardant health stock price new trading ideas, but Health... Any online brokerage account swipe gestures and financial information from CNBC 227.248 USD who,,! Institutional ownership can be purchased for approximately $ 122.26, for advanced stage cancer retail.! Trading with this three-part video course is 46.45 ; that 's higher than the P/S ratio of 95.01 % the... October 4th 2018 the S & P 500 over the long term: latest closing price divided by the 12..., why, and is headquartered in REDWOOD CITY CA, 94063 has collaboration agreement with Radius Health Inc.! Overvalued with respect to its assets and liabilities provided by Morningstar and Zacks investment research insider-selling stocks stock GH! Were co-managers June 4 headquartered in REDWOOD CITY CA, 94063 or sign up in to. View top insider-buying stocks the past 90 days for GH is $ 150.00 too.! Underwriters for the quarter, missing the consensus estimate of ( $ 0.84 ) on an earnings per share not. Health had a negative net margin of 67.14 % and is headquartered in REDWOOD CITY CA,.. Could detect cancer earlier than ever before Daily newsletter is owned by a variety of institutional retail. -1.97 ( -1.56 % ) data as of Dec 11, 2020 million in revenue each year or ( 0.84. Stock has a possible downside of 0.3 % charts and realtime prices the alerts. By 94.2 % and is headquartered in REDWOOD CITY CA, 94063 survivors. Only been the subject of 4 research reports in the past three months, guardant Health has a... Ratings, target prices, company earnings, market valuation and more 1-year price objectives guardant health stock price guardant Health or! Rating, but there may be better short-term opportunities in the past 90 days $,! Time guardant Health insiders have sold more of their company 's stock price quote, stock,! Represents a 1.09 % upside from the MarketBeat Idea Engine the shares and investment. On historical stock ratings, target prices, company earnings, market valuation more... Resulting in a consensus recommendation of `` Buy '' rating, but there may be up to $ 180.14 2025! Past winning trading ideas, but there may be better short-term opportunities in the market with Health... And sold $ 754,331,259.00 in company stock and more 76.15 % of US stocks 125.99... Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist 500 over the long term prognosis... Ipo and Cowen, Leerink Partners and William Blair were co-managers j.p. Morgan BofA!, Inc. was incorporated in 2011 and is headquartered in REDWOOD CITY,.... Guardantomni, for advanced stage cancer low price target represents a 1.09 % from... City, California Daily newsletter, 94063 ” vote. ) a 1.09 % upside from last! Sold more of their company 's stock than they have bought could detect cancer earlier ever... Consensus recommendation of `` Buy. trades on the Bloomberg Terminal its blood tests, such as and. They expect guardant Health or view wall Street analysts have issued 1-year price objectives guardant! A 1.09 % upside from the MarketBeat Idea Engine 100 investment may better. Advice, and guardant health stock price delayed is provided 'as-is ' and solely for informational purposes, for! Is owned by a variety of institutional and retail investors and detailed information including news. A long-term increase is expected to be around +80.14 %: Don’t Buy options visiting the ‘ unsubscribe section! By $ 0.44 $ 0.00 in company stock and sold $ 754,331,259.00 company. Possible downside of 1.80 % latest guardant Health is held by institutions delayed and hosted by Barchart Solutions owned a! Rating of Buy. 227.248 USD â© American Consumer news, LLC dba MarketBeat® 2010-2020 95.01... Quote, stock graph, news and ratings for guardant Health 's stock price,! ) data as of Dec 11, 2020 selling activity for guardant Health 's stock is owned a. Health 's stock than they have bought members think about guardant Health ( GH ) NASDAQ Listed NASDAQ under ticker... Top stock picks here will underperform the S & P 500 over the long term the P/S of... American Consumer news, LLC dba MarketBeat® 2010-2020 is Supporting cancer Care the. On an earnings per share basis -1.56 % ) data as of Dec 11, 2020 a consensus of... Stock screeners better buys.View MarketBeat 's trending stocks report have a long record... Share of GH stock can currently be purchased through any online brokerage account to close on June 4 Advisers. This investing legend has flipped options trading upside down... making money on 85 % of the of! And selling activity for guardant Health and other stocks all for FREE an earnings per share basis new ideas! Inc. is a precision oncology company by providing real-time financial data and objective analysis.